115 related articles for article (PubMed ID: 33326414)
21. Silencing of lncRNA MIR497HG via CRISPR/Cas13d Induces Bladder Cancer Progression Through Promoting the Crosstalk Between Hippo/Yap and TGF-β/Smad Signaling.
Zhuang C; Liu Y; Fu S; Yuan C; Luo J; Huang X; Yang W; Xie W; Zhuang C
Front Mol Biosci; 2020; 7():616768. PubMed ID: 33363213
[TBL] [Abstract][Full Text] [Related]
22. Establishing a Urine-Based Biomarker Assay for Prostate Cancer Risk Stratification.
Guo J; Liu D; Zhang X; Johnson H; Feng X; Zhang H; Wu AHB; Chen L; Fang J; Xiao Z; Xiao K; Persson JL; Zou C
Front Cell Dev Biol; 2020; 8():597961. PubMed ID: 33363151
[TBL] [Abstract][Full Text] [Related]
23. Upper Urinary Tract Tumors: Variant Histology Versus Urothelial Carcinoma.
Deuker M; Stolzenbach LF; Collà Ruvolo C; Nocera L; Tian Z; Roos FC; Becker A; Kluth LA; Tilki D; Shariat SF; Saad F; Chun FKH; Karakiewicz PI
Clin Genitourin Cancer; 2021 Apr; 19(2):117-124. PubMed ID: 33358490
[TBL] [Abstract][Full Text] [Related]
24. Lycopene Does Not Affect Prostate-Specific Antigen in Men with Non-Metastatic Prostate Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Sadeghian M; Asadi M; Rahmani S; Sadeghi N; Hosseini SA; Zare Javid A
Nutr Cancer; 2021; 73(11-12):2796-2807. PubMed ID: 33355018
[TBL] [Abstract][Full Text] [Related]
25. Pathology grade influences competing mortality risks in elderly men with prostate cancer.
Alam MU; Kumar J; Norez D; Tanneru K; Jazayeri SB; Bazargani S; Costa J; Bandyk M; Ganapathi HP; Koochekpour S; Gautam S; Balaji KC
Urol Oncol; 2021 Aug; 39(8):493.e1-493.e7. PubMed ID: 33353870
[TBL] [Abstract][Full Text] [Related]
26. Clinical outcomes and molecular profiling of advanced metastatic castration-resistant prostate cancer patients treated with
van der Doelen MJ; Mehra N; van Oort IM; Looijen-Salamon MG; Janssen MJR; Custers JAE; Slootbeek PHJ; Kroeze LI; Bruchertseifer F; Morgenstern A; Haberkorn U; Kratochwil C; Nagarajah J; Gerritsen WR
Urol Oncol; 2021 Oct; 39(10):729.e7-729.e16. PubMed ID: 33353867
[TBL] [Abstract][Full Text] [Related]
27. Oncologic and patient-reported outcomes after robot-assisted radical prostatectomy in men aged ≥75 years.
Togashi K; Hatakeyama S; Okamoto T; Kojima Y; Iwamura H; Fujita N; Narita T; Hamano I; Hamaya T; Yoneyama T; Yamamoto H; Yoneyama T; Hashimoto Y; Ohyama C
Urol Oncol; 2021 Oct; 39(10):729.e17-729.e25. PubMed ID: 33353866
[TBL] [Abstract][Full Text] [Related]
28. Decision regret, adverse outcomes, and treatment choice in men with localized prostate cancer: Results from a multi-site randomized trial.
Berry DL; Hong F; Blonquist TM; Halpenny B; Xiong N; Filson CP; Master VA; Sanda MG; Chang P; Chien GW; Jones RA; Krupski TL; Wolpin S; Wilson L; Hayes JH; Trinh QD; Sokoloff M
Urol Oncol; 2021 Aug; 39(8):493.e9-493.e15. PubMed ID: 33353864
[TBL] [Abstract][Full Text] [Related]
29. Therapies for Clinically Localized Prostate Cancer: A Comparative Effectiveness Review.
Wilt TJ; Ullman KE; Linskens EJ; MacDonald R; Brasure M; Ester E; Nelson VA; Saha J; Sultan S; Dahm P
J Urol; 2021 Apr; 205(4):967-976. PubMed ID: 33350857
[TBL] [Abstract][Full Text] [Related]
30. [French ccAFU guidelines - update 2020-2022: prostate cancer].
Rozet F; Mongiat-Artus P; Hennequin C; Beauval JB; Beuzeboc P; Cormier L; Fromont-Hankard G; Mathieu R; Ploussard G; Renard-Penna R; Brenot-Rossi I; Bruyere F; Cochet A; Crehange G; Cussenot O; Lebret T; Rebillard X; Soulié M; Brureau L; Méjean A
Prog Urol; 2020 Nov; 30(12S):S136-S251. PubMed ID: 33349424
[TBL] [Abstract][Full Text] [Related]
31. Direct interaction of β-catenin with nuclear ESM1 supports stemness of metastatic prostate cancer.
Pan KF; Lee WJ; Chou CC; Yang YC; Chang YC; Chien MH; Hsiao M; Hua KT
EMBO J; 2021 Feb; 40(4):e105450. PubMed ID: 33347625
[TBL] [Abstract][Full Text] [Related]
32. Hypofractionated Radiation Therapy to the Prostate Bed With Intensity-Modulated Radiation Therapy (IMRT): A Phase 2 Trial.
Leite ETT; Ramos CCA; Ribeiro VAB; Salvajoli BP; Nahas WC; Salvajoli JV; Ynoe Moraes F
Int J Radiat Oncol Biol Phys; 2021 Apr; 109(5):1263-1270. PubMed ID: 33346091
[TBL] [Abstract][Full Text] [Related]
33. Full recovery of a stage IV cancer patient facing COVID-19 pandemic.
Parmanande A; Simão D; Sardinha M; Dos Reis AFP; Spencer AS; Barreira JV; da Luz R
Autops Case Rep; 2020 Jun; 10(3):e2020179. PubMed ID: 33344300
[TBL] [Abstract][Full Text] [Related]
34. Impact of Time to Castration Resistance on Cytoreductive Radiotherapy in Metastatic Castration-Resistant Prostate Cancer.
Mai L; Zhang Z; Li Y; Liu R; Li J; Huang S; Lin M; Liu B; Cao W; Wu J; Liu M; Zhou F; Liu Y; He L
Front Oncol; 2020; 10():606133. PubMed ID: 33344256
[TBL] [Abstract][Full Text] [Related]
35. Commercialized Blood-, Urinary- and Tissue-Based Biomarker Tests for Prostate Cancer Diagnosis and Prognosis.
Visser WCH; de Jong H; Melchers WJG; Mulders PFA; Schalken JA
Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33339117
[TBL] [Abstract][Full Text] [Related]
36. An operative guide to laparoscopic dissection for total pelvic exenteration in a man with rectal cancer infiltrating the prostate and seminal vesicles - a video vignette.
Philip Sridhar R; Varghese G; John RA; Ranjan Jesudason M
Colorectal Dis; 2021 Mar; 23(3):767-768. PubMed ID: 33338324
[No Abstract] [Full Text] [Related]
37. Immune response drives outcomes in prostate cancer: implications for immunotherapy.
Meng J; Zhou Y; Lu X; Bian Z; Chen Y; Zhou J; Zhang L; Hao Z; Zhang M; Liang C
Mol Oncol; 2021 May; 15(5):1358-1375. PubMed ID: 33338321
[TBL] [Abstract][Full Text] [Related]
38. Predictive clinical features for negative histopathology of MRI/Ultrasound-fusion-guided prostate biopsy in patients with high likelihood of cancer at prostate MRI: Analysis from a urologic outpatient clinic1.
Apfelbeck M; Pfitzinger P; Bischoff R; Rath L; Buchner A; Mumm JN; Schlenker B; Stief CG; Chaloupka M; Clevert DA
Clin Hemorheol Microcirc; 2020; 76(4):503-511. PubMed ID: 33337358
[TBL] [Abstract][Full Text] [Related]
39. Diagnostic performance of prostate cancer antigen 3 and the Prostate Health Index in detecting overall and clinically significant prostate cancer in men at first biopsy: A meta-analysis.
Jia W; Wu B; Shao Y; Cao X; Wang D
Int J Urol; 2021 Mar; 28(3):315-325. PubMed ID: 33336418
[TBL] [Abstract][Full Text] [Related]
40. Prognostic implications of dual tracer PET/CT: PSMA ligand and [
Michalski K; Ruf J; Goetz C; Seitz AK; Buck AK; Lapa C; Hartrampf PE
Eur J Nucl Med Mol Imaging; 2021 Jun; 48(6):2024-2030. PubMed ID: 33336265
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
